Remove 2018 Remove Finance Remove Individual Remove Management
article thumbnail

Medical Equipment Costs Strain Cancer Survivors’ Finances

Physician's Weekly

prevalence of equipment use in 2018 was much lower than previously reported rates of mobility disability (27.9%) among cancer survivors, indicating issues with access,” they add. Almost half of hospital case managers have reported difficulties obtaining equipment for Medicare beneficiaries, the researchers noted. Of these, 10.2

Finance 52
article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

Associate Professor & Dr. Longtao He, Research Institute of Social Development, Southwestern University of Finance and Economics, Chengdu, China. Ebola-related stigma in Ghana: Individual and community level determinants. Shaanxi, Xi’an, China: Shaanxi Normal University; 2018. Scholars such as Wen et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Make an Alzheimer’s Diagnosis in Primary Care: A Podcast with Nathaniel Chin

GeriPal

On todays podcast, weve invited Nathaniel Chin back to the GeriPal podcast to talk about what primary care needs to manage this new world of Alzheimers disease effectively. And then the family tells me they can’t keep an appointment, they can’t manage their finances. Of these interventions in those individuals.

article thumbnail

Trump Whacks Agency That Makes the Nation’s Health Care Safer

Physicians News Digest

But neither Kennedy nor President Donald Trump have explained why individual agencies such as AHRQ were targeted for cuts or indicated whether any of their work would continue. But when the Trump administration proposed merging it with NIH in 2018, a House-ordered study into health research priorities validated AHRQ’s valuable role.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

In 2018, Trump’s Department of Health and Human Services (HHS) released its Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs , but the edifice envisioned by the Blueprint largely failed to materialize. Drug Price Negotiation to Benefit Medicare and Commercial Plans.